肝血管瘤插管硬化治疗的临床应用,拓宽了肝血管瘤外科治疗的途径。该疗法可避免肝叶切除的危险,操作简单,损伤小,较为安全。但在某些条件下也可能发生严重并发症,应引起足够重视。作者收集自1989年以来采用肝动脉插管硬化治疗肝血管瘤引起严重并发症5例(肝左叶巨大囊肿1例,肝门部胆管狭窄1例,肝内胆管一动脉瘘2例,化学性胆囊炎1例),报告如下。 1 病历资料例1.男性,35岁。1991年10月因肝脏巨大海绵状血管瘤行肝固有动脉结扎插管术,瘤体30cm×25cm×18cm,占据肝左叶和右叶大部。术后经插管灌注40%脲素溶液,每次7～10ml,每周3次,共20次;99.8%乙醇液,每次 The clinical application of hepatic hemangioma intubation sclerotherapy has broadened the surgical approach of hepatic hemangioma. This therapy can avoid the risk of hepatic lobectomy. It is easy to operate, less damaged and safer. However, serious complications may occur under certain conditions and should be given sufficient attention. The authors collected 5 cases of hepatic hemangioma caused by hepatic arterial sclerotherapy since 1989 and caused severe complications (1 case of hepatic left giant cyst, 1 case of hilar bile duct stenosis, and 2 cases of intrahepatic bile duct-artery fistula, chemical 1 case of cholecystitis), the report is as follows. 1 Medical Record Information Example 1. Male, 35 years old. In October 1991, hepatic proper artery ligation and cannulation was performed for massive cavernous hemangioma of the liver. The tumor body was 30cm × 25cm × 18cm, occupying the left lobe of the liver and most of the right lobe. Postoperatively infusing 40% urea solution, 7 to 10 ml each time, 3 times per week for 20 times; 99.8% ethanol solution, each time